IQVIA Holdings has significantly outperformed the broader S&P 500 Index in recent months, and analysts remain strongly ...

Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme") today announced the election of Jim Lang to its Board of Directors.

Over the last decade, the number of cell and gene therapy clinical trials has more than tripled. In this article, several ...

IQVIA , a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, today announced a strategic ...

IQVIA and AWS said the collaboration reflects the growing need for cloud-based tools that can support large-scale trial ...

With new UK clinical trial rules landing in 2026, the EU Biotech Act on the horizon and China and Australia gaining ground, ...

Biotech and pharma greenhouse gas emissions are falling – but is current progress fast enough? Discover My Green Lab’s Impact ...

The Life Sciences BPO Market is expanding rapidly, driven by rising R&D costs, increasing regulatory complexities and the growing need for operational efficiency across pharma and biotech sectors.

After 2024, which saw a steady recovery by the life sciences industry, it looks like 2025 is set to be a year of change and development, particularly in clinical trials. The good news is that ...

RFID-enabled, temperature-controlled cabinets represent a critical advancement for hospital and health system pharmacies, ...

John Wiley & Sons, Inc. (NYSE:WLY) Q2 2026 Earnings Call Transcript December 4, 2025 John Wiley & Sons, Inc. beats earnings ...

Intelliguard, a leading provider of automated medication management and data-intelligence solutions, today announced the launch of its Mira Caretm RFID temperature-controlled cabinet for transparent ...